» Articles » PMID: 39175728

Risk of Early Hepatocellular Carcinoma Recurrence Following Liver Resection: Arbitrary Specification or Possible Target to Improve Outcome?

Overview
Date 2024 Aug 23
PMID 39175728
Authors
Affiliations
Soon will be listed here.
References
1.
Martinino A, Bucaro A, Cardella F, Wazir I, Frongillo F, Ardito F . Liver transplantation vs liver resection in HCC: promoting extensive collaborative research through a survival meta-analysis of meta-analyses. Front Oncol. 2024; 14:1366607. PMC: 10986178. DOI: 10.3389/fonc.2024.1366607. View

2.
Allaire M, Goumard C, Lim C, Cleach A, Wagner M, Scatton O . New frontiers in liver resection for hepatocellular carcinoma. JHEP Rep. 2020; 2(4):100134. PMC: 7360891. DOI: 10.1016/j.jhepr.2020.100134. View

3.
Yan W, Li C, Yao L, Qiu H, Wang M, Xu X . Predictors and long-term prognosis of early and late recurrence for patients undergoing hepatic resection of hepatocellular carcinoma: a large-scale multicenter study. Hepatobiliary Surg Nutr. 2023; 12(2):155-168. PMC: 10129892. DOI: 10.21037/hbsn-21-288. View

4.
Kim H, An J, Kim J, Shin H, Park S, Song G . Postresection Period-Specific Hazard of Recurrence as a Framework for Surveillance Strategy in Patients with Hepatocellular Carcinoma: A Multicenter Outcome Study. Liver Cancer. 2022; 11(2):141-151. PMC: 9109079. DOI: 10.1159/000518837. View

5.
Chan K, Tay W, Cheo F, Shelat V . Preoperative transarterial chemoembolization (TACE) + liver resection versus upfront liver resection for large hepatocellular carcinoma (≥5 cm): a systematic review and meta-analysis. Acta Chir Belg. 2023; 123(6):601-617. DOI: 10.1080/00015458.2023.2256539. View